BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klein S, Frohn F, Magdaleno F, Reker-Smit C, Schierwagen R, Schierwagen I, Uschner FE, van Dijk F, Fürst DO, Djudjaj S, Boor P, Poelstra K, Beljaars L, Trebicka J. Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats. Sci Rep 2019;9:2256. [PMID: 30783172 DOI: 10.1038/s41598-019-38678-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Nevzorova YA, Boyer-diaz Z, Cubero FJ, Gracia-sancho J. Animal models for liver disease – A practical approach for translational research. Journal of Hepatology 2020;73:423-40. [DOI: 10.1016/j.jhep.2020.04.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 18.5] [Reference Citation Analysis]
2 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Poelstra K. Innovative Nanotechnological Formulations to Reach the Hepatic Stellate Cell. Curr Tissue Microenviron Rep 2020;1:13-22. [DOI: 10.1007/s43152-020-00004-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kaps L, Schuppan D. Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells 2020;9:E2027. [PMID: 32899119 DOI: 10.3390/cells9092027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
5 Huang Z, Khalifa MO, Li P, Huang Y, Gu W, Li TS. Angiotensin receptor blocker alleviates liver fibrosis by altering the mechanotransduction properties of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2022. [PMID: 35138187 DOI: 10.1152/ajpgi.00238.2021] [Reference Citation Analysis]
6 Sousa-Lima I, Kim HJ, Jones J, Kim YB. Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases. Diabetes Metab J 2021;45:655-74. [PMID: 34610720 DOI: 10.4093/dmj.2021.0197] [Reference Citation Analysis]
7 Wu X, Verschut V, Woest ME, Ng-Blichfeldt JP, Matias A, Villetti G, Accetta A, Facchinetti F, Gosens R, Kistemaker LEM. Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair. Front Pharmacol 2020;11:609509. [PMID: 33551810 DOI: 10.3389/fphar.2020.609509] [Reference Citation Analysis]
8 Liu J, Wu Y, Zhang Z, Li P. Tanshinone IIA improves sepsis-induced acute lung injury through the ROCK2/NF-κB axis. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.116021] [Reference Citation Analysis]
9 Landry T, Shookster D, Huang H. Tissue-Specific Approaches Reveal Diverse Metabolic Functions of Rho-Kinase 1. Front Endocrinol (Lausanne) 2020;11:622581. [PMID: 33633690 DOI: 10.3389/fendo.2020.622581] [Reference Citation Analysis]
10 Salvati A, Poelstra K. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation. Pharmaceutics 2022;14:217. [DOI: 10.3390/pharmaceutics14010217] [Reference Citation Analysis]
11 Brusilovskaya K, Königshofer P, Lampach D, Szodl A, Supper P, Bauer D, Beer A, Stift J, Timelthaler G, Oberhuber G, Podesser BK, Seif M, Zinober K, Rohr-Udilova N, Trauner M, Reiberger T, Schwabl P. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats. United European Gastroenterol J 2020;8:1174-85. [PMID: 32878579 DOI: 10.1177/2050640620944140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kitamura I, Hara M, Nagano S, Seki T. Photo-triggered surface relief formation of polystyrene films based on the Marangoni flow driven by a surface photoresponsive skin layer. Molecular Crystals and Liquid Crystals 2021;727:52-64. [DOI: 10.1080/15421406.2021.1946966] [Reference Citation Analysis]